B. Green

发表

Electrospray ionization mass spectrometry as a mechanistic tool: mass of human leucocyte elastase and a beta-lactam-derived E-I complex.

B. Shushan, T. Lee, J. Shively, 1993, Biochemistry.

Characterization of Inducible Nitric-oxide Synthase by Cytochrome P-450 Substrates and Inhibitors

J. Kozarich, S. Grant, Regina W. Wang, 1997, The Journal of Biological Chemistry.

Evidence that insulin and concanavalin-A can co-bind to solubilized insulin receptors without inhibiting each other.

H. Katzen, D. Soderman, B. Green, 1981, Biochemical and biophysical research communications.

Evidence that the insulin-like activities of concanavalin A and insulin are mediated by a common insulin receptor linked effector system.

P. Vicario, R. Mumford, H. Katzen, 1981, Biochemistry.

Impaired insulin-like growth factor I-mediated stimulation of glucose incorporation into glycogen in vivo in the ob/ob mouse

M. Bayne, P. Vicario, E. Slater, 1989, Diabetologia.

Serum half-life and biological activity of mutants of human insulin-like growth factor I which do not bind to serum binding proteins.

M. Bayne, N. Hayes, G. Chicchi, 1988, Endocrinology.

Proteoglycan-degrading activity of human stromelysin-1 and leukocyte elastase in rabbit joints. Quantitation of proteoglycan and a stromelysin-induced HABR fragment of aggrecan in synovial fluid and cartilage.

W. Hagmann, J. Hale, R. Mumford, 1996, Connective tissue research.

The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor.

D. Underwood, M. Bayne, N. Hayes, 1989, The Journal of biological chemistry.

Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors.

M. Bayne, N. Hayes, G. Chicchi, 1989, The Journal of biological chemistry.

Expression, purification and characterization of recombinant human insulin-like growth factor I in yeast.

M. Bayne, N. Hayes, G. Chicchi, 1988, Gene.

Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor.

M. Bayne, N. Hayes, G. Chicchi, 1988, The Journal of biological chemistry.

Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor.

M. Bayne, N. Hayes, G. Chicchi, 1988, Biochemistry.

Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.

J. Kozarich, S. Grant, S. K. Shah, 1998, Biochemistry.

Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.

S. Grant, R. Harrison, B. Green, 1993, Biochemical and biophysical research communications.

Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.

M. Maccoss, W. Hagmann, S. Grant, 2000, Bioorganic & medicinal chemistry letters.

The effect of iron substrate on mitochondria1 haem synthesis in copper deficiency

D. Williams, F. S. Kennedy, B. Green, 1985, British Journal of Nutrition.

Hepatic iron accumulation in copper-deficient rats

D. Williams, F. S. Kennedy, B. Green, 1983, British Journal of Nutrition.

Identification of the insulin-like growth factor I (IGF I) epitopes recognized by monoclonal and polyclonal antibodies to IGF I.

M. Bayne, G. Chicchi, M. Cascieri, 1990, Endocrinology.

Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase.

M. Maccoss, S. Grant, R. Chabin, 2005, Bioorganic & medicinal chemistry letters.

Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.

J. Kozarich, S. Grant, B. Green, 2001, Bioorganic chemistry.

Analysis of the interaction of IGF I and structural mutants of IGF I with the IGF types 1 and 2 and insulin receptors

M. Bayne, N. Hayes, G. Chicchi, 1988 .

Mechanism of inhibition of human leucocyte elastase by monocyclic beta-lactams.

M. Maccoss, W. Hagmann, R. Chabin, 1993, Biochemistry.

Inhibition of human serine proteases by substituted 2-azetidinones.

R. Chabin, W. Knight, B. Green, 1992, Archives of biochemistry and biophysics.

Mechanism of inhibition of human leukocyte elastase by two cephalosporin derivatives.

W. Hagmann, A. Maycock, J. Doherty, 1992, Biochemistry.

Potency of antileukoprotease and alpha 1-antitrypsin to inhibit degradation of fibrinogen by adherent polymorphonuclear leukocytes from normal subjects and patients with chronic granulomatous disease.

W. Hanlon, J. Stolk, J. Dijkman, 1992, American journal of respiratory cell and molecular biology.

PMN elastases: a comparison of the specificity of human isozymes and the enzyme from other species toward substrates and inhibitors.

M. Lark, W. Hagmann, A. Maycock, 1991, Archives of biochemistry and biophysics.

Inhibition of bacterial peptide deformylase by biaryl acid analogs.

J. Kozarich, S. Grant, J. Toney, 2000, Archives of biochemistry and biophysics.

Specificity, stability, and potency of monocyclic beta-lactam inhibitors of human leucocyte elastase.

W. M. Westler, R. Chabin, A. Maycock, 1992, Biochemistry.

Mechanism of inhibition of human leucocyte elastase by beta-lactams. 2. Stability, reactivation kinetics, and products of beta-lactam-derived E-I complexes.

D. Underwood, R. Chabin, A. Maycock, 1995, Biochemistry.

Mechanism of inhibition of human leucocyte elastase by beta-lactams. 3. Use of electrospray ionization mass spectrometry and two-dimensional NMR techniques to identify beta-lactam-derived E-I complexes.

D. Underwood, M. Maccoss, R. Chabin, 1995, Biochemistry.

Comparison of the proteoglycanolytic activities of human leukocyte elastase and human cathepsin G in vitro and in vivo.

M. Lark, M. Poe, V. Moore, 1993, Connective tissue research.

2-Iminobiotin is an inhibitor of nitric oxide synthases.

S. Grant, B. Green, S. J. Sup, 1994, Biochemical and biophysical research communications.

Inhibition of nitric oxide synthase by benzoxazolones

M. Maccoss, S. Grant, Shrenik K. Shah, 1997 .

Peptide aldehyde inhibitors of bacterial peptide deformylases.

S. Grant, B. Green, D. J. Durand, 1999, Archives of biochemistry and biophysics.